| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Annals of Surgical Oncology, Vol 5, Issue 8 699-705, Copyright © 1998 by Society of Surgical Oncology
ARTICLES |
A. M. Rijken, A. Umezawa, T. M. van Gulik, A. Bosma, M. M. Polak, G. J. Offerhaus, H. Obertop and D. J. Gouma
Department of Surgery, Academic Medical Center, University of Amsterdam, The Netherlands.
BACKGROUND: The aim of this study was to investigate the prognostic value of cell proliferation (Ki-67 antigen) and DNA content in patients resected for distal bile duct carcinoma (DBDC). METHODS: Formalin-fixed tumor specimens of 35 patients with resected DBDC and a long-term clinical follow-up were analyzed. MIB-1 antibody was used for Ki-67 antigen detection to determine the proportion of proliferating cells. DNA content was measured using flow cytometry. RESULTS: A significant correlation was found between a low MIB-1 index (<20%) and survival (P <.05). Of the 35 tumor specimens, 34 specimens were evaluable by flow cytometry: 22 carcinomas were diploid (65%), and 12 were aneuploid (35%). The median DNA index of aneuploid tumors was 1.36 (range, 1.09 to 1.76). No correlation of DNA-ploidy with survival time was found. CONCLUSION: In contrast to DNA-ploidy pattern, Ki-67 antigen expression showed prognostic significance in resectable DBDC. A Ki-67 positive ratio of > or =20% was associated with decreased survival time.
This article has been cited by other articles:
![]() |
Q. Cheng, X. Luo, B. Zhang, X. Jiang, B. Yi, and M. Wu Distal Bile Duct Carcinoma: Prognostic Factors After Curative Surgery. A Series of 112 Cases Ann. Surg. Oncol., March 1, 2007; 14(3): 1212 - 1219. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fiorentino, A. Altimari, A. D'Errico, E. Gabusi, P. Chieco, M. Masetti, and W. F. Grigioni Low p27 Expression Is an Independent Predictor of Survival for Patients with Either Hilar or Peripheral Intrahepatic Cholangiocarcinoma Clin. Cancer Res., December 1, 2001; 7(12): 3994 - 3999. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |